Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan.

ADT in the treatment of prostate cancer may not be associated with an increased risk of ischemic stroke. The differences in thromboembolic effects in cardiovascular disease and ischemic stroke secondary to ADT should be further discussed and evaluated prospectively.